A new proteomic strategy combining functionalized magnetic nanoparticle affinity probes with mass spectrometry was developed to capture and identify proteins specifically responding to 1，2-d(GpG) intrastrand cisplatin-cross-linked DNA， the major DNA lesion caused by cisplatin and thought to induce apoptosis. A 16-mer oligodeoxynucleotide (ODN) duplex and its cisplatin-cross-linked adduct were immobilized on magnetic nanoparticles via click reaction， respectively， to fabricate negative and positive affinity probes which were very stable in cellular protein extracts due to the excellent bio-orthogonality of click chemistry and the inertness of covalent triazole linker. Quantitative mass spectrometry resul... More
A new proteomic strategy combining functionalized magnetic nanoparticle affinity probes with mass spectrometry was developed to capture and identify proteins specifically responding to 1，2-d(GpG) intrastrand cisplatin-cross-linked DNA， the major DNA lesion caused by cisplatin and thought to induce apoptosis. A 16-mer oligodeoxynucleotide (ODN) duplex and its cisplatin-cross-linked adduct were immobilized on magnetic nanoparticles via click reaction， respectively， to fabricate negative and positive affinity probes which were very stable in cellular protein extracts due to the excellent bio-orthogonality of click chemistry and the inertness of covalent triazole linker. Quantitative mass spectrometry results unambiguously revealed the predominant binding of HMGB1 and HMGB2， the well-established specific binders of 1，2-cisplatin-cross-linked DNA， to the cisplatin-cross-linked ODN， thus validating the accuracy and reliability of our strategy. Furthermore， 5 RNA or single-stranded DNA binding proteins， namely， hnRNP A/B， RRP44， RL30， RL13， and NCL， were demonstrated to recognize specifically the cisplatinated ODN， indicating the significantly unwound ODN duplex by cisplatin cross-linking. In contrast， the binding of a transcription factor TFIIFa to DNA was retarded due to cisplatin damage， implying that the cisplatin lesion stalls DNA transcription. These findings promote understanding in the cellular responses to cisplatin-damaged DNA and inspire further precise elucidation of the action mechanism of cisplatin.
